How the pandemic and George Floyd made clinical trial diversity a priority

July 05, 2022

Clario Chief Diversity, Inclusion & Sustainability Officer Otis Johnson, Ph.D., M.P.A., sat down with Drug Discovery and Development to discuss how COVID-19 shone a light on the lack of diversity in clinical trials. Read the full article here.